The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival after brain metastases in Asian patients with HER2+ breast cancer.
Y. S. Yap
Research Funding - GlaxoSmithKline
B. C. Devi
Research Funding - GlaxoSmithKline
C. Khorprasert
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
G. H. Cornelio
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
N. Sutandyo
Research Funding - GlaxoSmithKline
E. Yeoh
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
S. Landis
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
M. Kobayashi
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
H. Moon
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
J. Ro
Consultant or Advisory Role - GlaxoSmithKline; Pfizer
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline